Current share price values the company at just over $10m.
IMO the IP is worth far more than this.
The likes of APT and OPY are partnering with 1ST because their platform is robust and it would take each of them years to develop. At this price I think one of these coys seriously considers acquiring 1ST to integrate with their platforms internationally.
Either that or the likes of Coviu, healthengine or hotdoc will start sniffing around to secure a larger market share.
Ann: Interim CEO Appointment, page-54
Add VFX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 11076656 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5749999 | 5 |
View Market Depth
| Last trade - 10.09am 09/07/2024 (20 minute delay) ? |
| VFX (ASX) Chart |
Day chart unavailable